CA2078220A1 - Synthetic polypeptides - Google Patents

Synthetic polypeptides

Info

Publication number
CA2078220A1
CA2078220A1 CA002078220A CA2078220A CA2078220A1 CA 2078220 A1 CA2078220 A1 CA 2078220A1 CA 002078220 A CA002078220 A CA 002078220A CA 2078220 A CA2078220 A CA 2078220A CA 2078220 A1 CA2078220 A1 CA 2078220A1
Authority
CA
Canada
Prior art keywords
amino acid
gly
gln
leu
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002078220A
Other languages
English (en)
French (fr)
Inventor
Robert V. Fishleigh
Barry Robson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protherics Medicines Development Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2078220A1 publication Critical patent/CA2078220A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002078220A 1990-03-15 1991-03-13 Synthetic polypeptides Abandoned CA2078220A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9005829.8 1990-03-15
GB909005829A GB9005829D0 (en) 1990-03-15 1990-03-15 Synthetic polypeptides

Publications (1)

Publication Number Publication Date
CA2078220A1 true CA2078220A1 (en) 1991-09-16

Family

ID=10672665

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002078220A Abandoned CA2078220A1 (en) 1990-03-15 1991-03-13 Synthetic polypeptides

Country Status (17)

Country Link
EP (1) EP0519986A1 (cs)
JP (1) JPH05505188A (cs)
CN (1) CN1054772A (cs)
AP (1) AP211A (cs)
AU (1) AU636735B2 (cs)
BR (1) BR9106159A (cs)
CA (1) CA2078220A1 (cs)
CS (1) CS68091A2 (cs)
FI (1) FI923800A0 (cs)
GB (1) GB9005829D0 (cs)
HU (1) HUT63179A (cs)
IL (1) IL97551A0 (cs)
MX (1) MX24890A (cs)
NZ (1) NZ237417A (cs)
OA (1) OA09671A (cs)
WO (1) WO1991013909A1 (cs)
ZA (1) ZA911886B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657590B2 (en) * 1991-11-04 1995-03-16 Dade International Inc. Synthetic peptides corresponding to portions of HIV-2 virus and methods of using in an improved assay
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
EP0633881B1 (en) * 1992-03-11 2003-10-29 Narhex Limited Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
US6511845B1 (en) 1992-08-07 2003-01-28 Alan R. Davis Methods for producing an immune response against HIV-1
ATE258188T1 (de) 1992-08-27 2004-02-15 Deakin Res Ltd Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DE4402756A1 (de) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
CN1472314A (zh) * 2002-07-29 2004-02-04 清华大学 艾滋病病毒o型株的一个免疫学表位及其应用
CN100445296C (zh) * 2006-03-31 2008-12-24 浙江大学 多肽有机化合物及其在异种移植中的应用
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
GB201612108D0 (en) 2016-07-12 2016-08-24 Univ Strathclyde Preperation of non-ionic surfactant vesicles and variants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
ATE87487T1 (de) * 1987-11-16 1993-04-15 Hoffmann La Roche Rekombinante hiv-2 polypeptide.

Also Published As

Publication number Publication date
AU636735B2 (en) 1993-05-06
BR9106159A (pt) 1993-03-16
GB9005829D0 (en) 1990-05-09
AP211A (en) 1992-10-21
ZA911886B (en) 1991-12-24
HUT63179A (en) 1993-07-28
NZ237417A (en) 1993-10-26
IL97551A0 (en) 1992-06-21
FI923800A7 (fi) 1992-08-24
MX24890A (es) 1993-12-01
EP0519986A1 (en) 1992-12-30
CN1054772A (zh) 1991-09-25
WO1991013909A1 (en) 1991-09-19
AU7467991A (en) 1991-10-10
FI923800L (fi) 1992-08-24
HU9202939D0 (en) 1992-12-28
CS68091A2 (en) 1991-12-17
OA09671A (en) 1993-05-15
JPH05505188A (ja) 1993-08-05
FI923800A0 (fi) 1992-08-24
AP9100245A0 (en) 1991-04-30

Similar Documents

Publication Publication Date Title
US5759769A (en) Tandem synthetic HIV-1 peptides
EP0616613B1 (en) Fragments of prion proteins
AP211A (en) Synthetic polypeptides.
AU732809B2 (en) Compositions and methods for treating viral infections
JPH04502760A (ja) エイズの診断，予防および治療に有効な新規ｈｉｖ蛋白質およびペプチド
EP0550599B1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
CA2118033A1 (en) Synthetic polypeptides derived from the hiv envelope gylcoprotein
US5346989A (en) Peptides for use in induction of T cell activation against HIV-1
WO1994002508A2 (en) Polypeptide antigens of mycobacterium bovis
EP0693938B1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
AU2006200454A1 (en) Compositions and methods for treating viral infections
AU2004201322A1 (en) Compositions and methods for treating viral infections
AU2006200455A1 (en) Compositions and methods for treating viral infections
AU2004208648A1 (en) Compositions and methods for treating infections

Legal Events

Date Code Title Description
FZDE Discontinued